A pH‐responsive Cascade Nano‐Reactor Elevates ROS Generation by Remodeling Biofilm Microenvironment for Enhanced Antibacterial Treatment
Source abstract
Abstract
Abstract Biofilms are the root of most chronic and persistent infections and pose a significant threat to human health. Reactive oxygen species (ROS) generation platforms have been used to combat biofilm‐associated infections. However, biofilm microenvironments (BME) such as hypoxia and overexpressed antioxidants restrict the efficacy of ROS‐based therapies. To address the problem, this study incorporates calcium peroxide (CaO2) and berberine (BBR) into Fe and Zn containing bimetal metal–organic frameworks (FZ) to construct a composite ROS nanogenerator (CBFZ), which is able to remodel BME and further promotes ROS generation for enhance biofilm eradication. CBFZ degrades to release CaO2, Fe3+, Fe2+, and BBR in biofilm, where CaO2 decomposes into O2 and H2O2 to relieve hypoxia, and Fe3+ consumes glutathione (GSH). Subsequently, the remodeled BME boosts the ROS production of the O2‐dependent BBR‐mediated photodynamic therapy and H2O2‐dependent Fe2+‐based chemodynamic therapy, and the depleted GSH minimizes ROS scavenging in the meantime, ultimately maintaining a high level of ROS in biofilm. It is demonstrated that CBFZ can effectively eradicate biofilm by killing the embedded bacteria and dispersing the biofilm matrix. Moreover, CBFZ exhibits an outstanding therapeutic effect in a murine model with subcutaneous biofilm infection. Overall, this work offers a propagable strategy to enhance ROS‐based antibiofilm therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Bacterial biofilms and quorum sensing
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Advanced Medical Materials and Devices Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine Key Laboratory of Radiopharmacokinetics for Innovative Drugs Tianjin Institutes of Health Science Institute of Radiation Medicine Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin 300192 China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Tianjin Municipality
References (51)
Show source-provided references
1. 10.1016/S0140-6736(21)02724-010.1016/S0140-6736(21)02724-0 ↗
2. O'neill J. · Rev. Antimicrob. Resist. · 2014 · 20 · 1
3. 10.1038/nrd100810.1038/nrd1008 ↗
4. 10.1038/s41579-022-00682-410.1038/s41579-022-00682-4 ↗
5. 10.1038/s41579-024-01086-210.1038/s41579-024-01086-2 ↗
6. 10.1038/s41579-022-00767-010.1038/s41579-022-00767-0 ↗
7. 10.1038/nrmicro.2016.9410.1038/nrmicro.2016.94 ↗
8. 10.1021/acsnano.0c0026910.1021/acsnano.0c00269 ↗
9. 10.1038/nrmicro.2017.9910.1038/nrmicro.2017.99 ↗
10. 10.1128/cmr.00024-2310.1128/cmr.00024-23 ↗
11. 10.1002/anie.20161092610.1002/anie.201610926 ↗
12. 10.1038/s41467-022-31479-x10.1038/s41467-022-31479-x ↗
13. 10.1039/D1CS00074H10.1039/D1CS00074H ↗
14. 10.1002/adma.20230343210.1002/adma.202303432 ↗
15. 10.1039/D0MH01921F10.1039/D0MH01921F ↗
16. 10.1038/s41467-024-52489-x10.1038/s41467-024-52489-x ↗
17. 10.1016/j.tplants.2016.08.00210.1016/j.tplants.2016.08.002 ↗
18. 10.1016/j.redox.2018.10108410.1016/j.redox.2018.101084 ↗
19. 10.1038/cddis.2011.13410.1038/cddis.2011.134 ↗
20. 10.1038/nrmicro.2017.2610.1038/nrmicro.2017.26 ↗
21. 10.1038/s41392-024-01969-z10.1038/s41392-024-01969-z ↗
22. 10.1039/C6CS00616G10.1039/C6CS00616G ↗
23. 10.1016/j.biomaterials.2020.11997210.1016/j.biomaterials.2020.119972 ↗
24. 10.1016/j.cej.2022.13721410.1016/j.cej.2022.137214 ↗
25. 10.1002/EXP.2023008710.1002/EXP.20230087 ↗
26. 10.1021/acsami.1c1968110.1021/acsami.1c19681 ↗
27. 10.1016/j.bioactmat.2022.07.00310.1016/j.bioactmat.2022.07.003 ↗
28. 10.1038/s41467-023-43067-810.1038/s41467-023-43067-8 ↗
29. 10.1016/j.bioflm.2024.10020310.1016/j.bioflm.2024.100203 ↗
30. 10.1016/j.ccr.2023.21548210.1016/j.ccr.2023.215482 ↗
31. 10.1186/s12951-024-02350-610.1186/s12951-024-02350-6 ↗
32. 10.1002/advs.20200049410.1002/advs.202000494 ↗
33. 10.1039/D1SC05482A10.1039/D1SC05482A ↗
34. 10.1016/j.nantod.2021.10116210.1016/j.nantod.2021.101162 ↗
35. 10.1002/anie.20190222910.1002/anie.201902229 ↗
36. 10.1039/C8CS00337H10.1039/C8CS00337H ↗
37. 10.1021/ja311687310.1021/ja3116873 ↗
38. 10.1016/j.jhazmat.2021.12604610.1016/j.jhazmat.2021.126046 ↗
39. 10.1021/acsnano.9b0549310.1021/acsnano.9b05493 ↗
40. 10.1016/j.actbio.2022.10.02010.1016/j.actbio.2022.10.020 ↗
41. 10.1002/adfm.20200053710.1002/adfm.202000537 ↗
42. 10.1002/advs.20180152610.1002/advs.201801526 ↗
43. 10.1016/j.actbio.2022.04.00410.1016/j.actbio.2022.04.004 ↗
44. 10.1038/s41467-020-15591-410.1038/s41467-020-15591-4 ↗
45. 10.1002/adfm.20170197410.1002/adfm.201701974 ↗
46. Liu J. · Int J Nanomedicine · 2010 · 6 · 59
47. 10.1038/s41598-022-18815-310.1038/s41598-022-18815-3 ↗
48. 10.1126/science.118862810.1126/science.1188628 ↗
49. 10.1093/femsle/fnv02510.1093/femsle/fnv025 ↗
50. 10.1099/mic.0.26634-010.1099/mic.0.26634-0 ↗
51. 10.1002/agt2.58710.1002/agt2.587 ↗